1. Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer
- Author
-
Lourdes Sanz, Antonio Fueyo, Omar Abdel-Laa, A. Martín, José M. del Casar, José L. García Muñiz, Francisco J. Vizoso, Miguel Bongera, and María D. Corte
- Subjects
Survival Status ,Oncology ,medicine.medical_specialty ,business.industry ,Cancer ,Cathepsin D ,General Medicine ,medicine.disease ,Gastroenterology ,Metastasis ,Protein catabolism ,Gastric adenocarcinoma ,Internal medicine ,Medicine ,Surgery ,business ,Prospective cohort study ,Pathological - Abstract
Background and Aims Cathepsin D (Cath-D) is an aspartyl protease involved in protein catabolism and tissue remodelling. In the present article, we evaluate the tumor content of Cath-D in resectable gastric carcinomas and its relation with clinical and pathological parameters, as well as its prognostic significance. Method This prospective study included a series of 60 patients with primary gastric adenocarcinoma, who first underwent a complete surgical resection of their tumors and then were evaluated for disease recurrence and survival status during a mean follow-up period of 41.5 months. Cath D was measured in cytosolic samples using an immune-radiometric assay which determined the total amount of Cath-D (52K, 48K, and 34K). Results The tumor content of Cath-D ranged from 4 to 247 pmol/mg protein and from 6.4 to 97.7 pmol/mg protein in adjacent non-neoplastic mucosa samples. Cytosolic Cath-D levels were significantly higher in neoplastic tissues (P
- Published
- 2004
- Full Text
- View/download PDF